The Asia Pacific Syphilis Testing Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
Penicillin is a common antibiotic that is generally effective in the treatment of syphilis. People who are allergic to penicillin would most likely be given an antibiotic such as doxycycline or ceftriaxone. The neurosyphilis, would be given daily intravenous penicillin dosages. A penicillin injection can be used to treat both primary and secondary syphilis. The effects of late syphilis are irreversible. Although the germs can be eradicated, most treatments would focus on reducing pain and discomfort. Avoid sexual contact throughout therapy until all sores on the body have healed and the doctor says it's safe to resume sex. If sexually active should treat their partner the same way. Wait until and partner has finished treatment before beginning sexual activity.
Higher-income countries are grappling with a concerning trend in the form of drug-resistant diseases. Laboratories are essential for people's physical and mental health, independent of their location or financial position. Advances in diagnostic testing have created new possibilities for the treatment of numerous infections, and understanding which testing is available is crucial to meeting the needs of local populations.
Sexually transmitted diseases (RTIs/STIs) and other reproductive tract infections (RTIs/STIs) have been recognized as a public health issue in India, due to their link to HIV infection. RTI/STI prevention, management, and treatment is a well-known method for reducing reproductive morbidity in the sexual activity population while simultaneously controlling HIV/AIDS spread in the country. Furthermore, the Government of India's National AIDS Control Program has increased STD testing in rural regions while also raising public awareness. During the 12-year research, 1069 HIV-positive men were examined for syphilis at least once after a negative baseline test, contributing to 4284 person-years of follow-up (PYFU). There were 266 cases of incident syphilis, for a total of 6.21 occurrences per 100 PYFU. Syphilis incidence per 100 PYFU enhanced from 1.21 in 2010 to 26.04 in 2017.
The China market dominated the Asia Pacific Syphilis Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $117 million by 2028. The Japan market is expeiencing a CAGR of 5.5% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 6.9% during (2022 - 2028).
Based on Type, the market is segmented into Primary & Secondary Syphilis and Others. Based on Location of Testing, the market is segmented into Laboratory testing and Point of care (POC) testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Syphilis Testing Market is Projected to reach USD 1.5 Billion by 2028, at a CAGR of 5.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG, Abbott Laboratories, DiaSorin S.p.A. (Luminex Corporation), Hologic, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher Corporation (Cepheid), and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Primary & Secondary Syphilis
- Others
By Location of Testing
- Laboratory testing
- Point of care (POC) testing
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Siemens Healthineers AG
- Abbott Laboratories
- DiaSorin S.p.A. (Luminex Corporation)
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Danaher Corporation (Cepheid)
- F. Hoffmann-La Roche Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Syphilis Testing Market, by Type
1.4.2 Asia Pacific Syphilis Testing Market, by Location of Testing
1.4.3 Asia Pacific Syphilis Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Syphilis Testing Market by Type
3.1 Asia Pacific Primary & Secondary Syphilis Market by Country
3.2 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Syphilis Testing Market by Location of Testing
4.1 Asia Pacific Laboratory testing Market by Country
4.2 Asia Pacific Point of care (POC) testing Market by Country
Chapter 5. Asia Pacific Syphilis Testing Market by Country
5.1 China Syphilis Testing Market
5.1.1 China Syphilis Testing Market by Type
5.1.2 China Syphilis Testing Market by Location of Testing
5.2 Japan Syphilis Testing Market
5.2.1 Japan Syphilis Testing Market by Type
5.2.2 Japan Syphilis Testing Market by Location of Testing
5.3 India Syphilis Testing Market
5.3.1 India Syphilis Testing Market by Type
5.3.2 India Syphilis Testing Market by Location of Testing
5.4 South Korea Syphilis Testing Market
5.4.1 South Korea Syphilis Testing Market by Type
5.4.2 South Korea Syphilis Testing Market by Location of Testing
5.5 Singapore Syphilis Testing Market
5.5.1 Singapore Syphilis Testing Market by Type
5.5.2 Singapore Syphilis Testing Market by Location of Testing
5.6 Malaysia Syphilis Testing Market
5.6.1 Malaysia Syphilis Testing Market by Type
5.6.2 Malaysia Syphilis Testing Market by Location of Testing
5.7 Rest of Asia Pacific Syphilis Testing Market
5.7.1 Rest of Asia Pacific Syphilis Testing Market by Type
5.7.2 Rest of Asia Pacific Syphilis Testing Market by Location of Testing
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Danaher Corporation (Cepheid)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Becton, Dickinson and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Thermo Fisher Scientific, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Bio-Rad laboratories, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expenses
6.6 Hologic, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent Strategies and Developments:
6.6.5.1 Approvals and Trials:
6.7 DiaSorin S.p.A. (Luminex Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent Strategies and Developments:
6.8.5.1 Approvals and Trials:
6.9 Siemens Healthineers AG (Siemens AG)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
TABLE 1 Asia Pacific Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Primary & Secondary Syphilis Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Primary & Secondary Syphilis Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Laboratory testing Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Laboratory testing Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Point of care (POC) testing Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Point of care (POC) testing Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Syphilis Testing Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Syphilis Testing Market by Country, 2022 - 2028, USD Million
TABLE 17 China Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 18 China Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 19 China Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 20 China Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 21 China Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 22 China Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 23 Japan Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 24 Japan Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 25 Japan Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 26 Japan Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 27 Japan Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 28 Japan Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 29 India Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 30 India Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 31 India Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 32 India Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 33 India Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 34 India Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 35 South Korea Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 36 South Korea Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 37 South Korea Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 38 South Korea Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 39 South Korea Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 40 South Korea Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 41 Singapore Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 42 Singapore Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 43 Singapore Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 44 Singapore Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 45 Singapore Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 46 Singapore Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 47 Malaysia Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 48 Malaysia Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 49 Malaysia Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 50 Malaysia Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 51 Malaysia Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 52 Malaysia Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 53 Rest of Asia Pacific Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 54 Rest of Asia Pacific Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 55 Rest of Asia Pacific Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 56 Rest of Asia Pacific Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 57 Rest of Asia Pacific Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 58 Rest of Asia Pacific Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 59 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 60 Key Information – Danaher Corporation
TABLE 61 Key information – Becton, Dickinson and Company
TABLE 62 Key Information – Thermo Fisher Scientific, Inc.
TABLE 63 Key Information – Bio-Rad Laboratories, Inc.
TABLE 64 Key information – Hologic, Inc.
TABLE 65 Key Information – DiaSorin S.p.A.
TABLE 66 Key Information – Abbott Laboratories
TABLE 67 Key Information – Siemens Healthineers AG
List of Figures
FIG 1 Methodology for the research